Cited by 319Bacterial Genetics and BiotechnologyAntimicrobial Resistance in StaphylococcusAntimicrobial Peptides and Activities

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins

Open access
Pogliano, J., Pogliano, N., Silverman, J. A.·2012·Journal of Bacteriology

Abstract

Daptomycin is a lipopeptide antibiotic used clinically for the treatment of certain types of Gram-positive infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). Details of the mechanism of action of daptomycin continue to be elucidated, particularly the question of whether daptomycin acts on the cell membrane, the cell wall, or both. Here, we use fluorescence microscopy to directly visualize the interaction of daptomycin with the model Gram-positive bacterium Bacillus subtilis. We show that the first observable cellular effects are the formation of membrane distortions (patches of membrane) that precede cell death by more than 30 min. Membrane patches are able to recruit the essential cell division protein DivIVA. Recruitment of DivIVA correlates with membrane defects and changes in cell morphology, suggesting a localized alteration in the activity of enzymes involved in cell wall synthesis that could account for previously described effects of daptomycin on cell wall morphology and septation. Membrane defects colocalize with fluorescently labeled daptomycin, DivIVA, and fluorescent reporters of peptidoglycan biogenesis (Bocillin FL and BODIPY FL-vancomycin), suggesting that daptomycin plays a direct role in these events. Our results support a mechanism for daptomycin with a primary effect on cell membranes that in turn redirects the localization of proteins involved in cell division and cell wall synthesis, causing dramatic cell wall and membrane defects, which may ultimately lead to a breach in the cell membrane and cell death. These results help resolve the longstanding questions regarding the mechanism of action of this important class of antibiotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jb.00011-12

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 1

  1. Ryter, 1965, Etude morphologie de la sporulation de Bacillus subtilis, Ann. Inst. Pasteur (Paris), 108, 40

Cited by

Sorted by citations

Metadata

Authors
Pogliano, J., Pogliano, N., & Silverman, J. A.
Affiliations
  • University of California San Diego (US)
  • Cubist Pharmaceuticals (United States) (US)
Venue
Journal of Bacteriology
Published
2012-06-01
Volume
194
Issue
17
Pages
4494-4504
ISSN
0021-9193 (ISSN-L)
OpenAlex
W2113063737
Cited by
319
References
59
Citations by year
2026: 8 · 2025: 10 · 2024: 23 · 2023: 19 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 27 · 2018: 23 · 2017: 30 · 2016: 30 · 2015: 29 · 2014: 25 · 2013: 18 · 2012: 5
FWCI
14.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Bacteriology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (R01GM073898, GM073898)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
Keywords
daptomycin, antibiotic mechanism of action, membrane deformation, DivIVA, cell division proteins, cell wall biosynthesis, Bacillus subtilis, methicillin-resistant Staphylococcus aureus, cell morphology, septation
MeSH terms
Anti-Bacterial Agents, Bacillus subtilis, Bacterial Proteins, Cell Division, Cell Membrane, Cell Wall, Microbial Sensitivity Tests, Microscopy, Fluorescence, Peptidoglycan, Daptomycin, Cell Cycle Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review